| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | CEO | President &CEO +3 more
4 companies
Kaye Edward M. Md is a Director at SRPT with holdings across 4 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $5.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2025 | CYTK Cytokinetics Inc | Director | Sell | 6,756 | $50.00 | $337,800.00 | -22.5% | +33.1% | - | |
| Aug 18, 2025 | STOK Stoke Therapeutics, Inc. | Director | Sell | 12,126 | $18.24 | $221,153.99 | -7.3% | +45.6% | - | |
| Jun 5, 2025 | CYTK Cytokinetics Inc | Director | Sell | 3,636 | $32.10 | $116,715.60 | -10.9% | +55.8% | - | |
| Mar 19, 2025 | STOK Stoke Therapeutics, Inc. | Director | Sell | 19,289 | $8.49 | $163,672.83 | -6.3% | +41.2% | +301.8% | |
| Dec 9, 2024 | STOK Stoke Therapeutics, Inc. | CEO | Sell | 6,786 | $12.99 | $88,158.28 | -9.9% | -42.2% | +121.4% | |
| Dec 6, 2024 | STOK Stoke Therapeutics, Inc. | CEO | Sell | 6,170 | $12.78 | $78,837.18 | -8.2% | -38.6% | +132.6% | |
| May 20, 2024 | STOK Stoke Therapeutics, Inc. | CEO | Sell | 42,350 | $15.43 | $653,529.16 | -42.8% | -7.8% | -37.6% | |
| Mar 19, 2024 | STOK Stoke Therapeutics, Inc. | CEO | Sale+OE | 11,150 | $6.10 | $67,999.39 | -13.9% | +169.0% | +42.4% | |
| Aug 5, 2022 | CYTK Cytokinetics Inc | Director | Sale+OE | 11,428 | $50.00 | $571,400.00 | -47.6% | -23.3% | -36.0% | |
| Dec 23, 2021 | CYTK Cytokinetics Inc | Director | Sale+OE | 15,000 | $45.00 | $675,000.00 | -68.9% | -16.7% | +2.1% |